05:18 PM EDT, 09/18/2024 (MT Newswires) -- Nanobiotix ( NBTX ) reported a H1 net loss late Wednesday of 0.46 euro ($0.51) per share, compared with a loss of 0.80 euro a year earlier.

Two analysts polled by Capital IQ expected a loss of 0.36 euro.

Revenue and other income for the six months ended June 30 rose to 9.3 million euros from 3.3 million euros a year earlier.

Analysts surveyed by Capital IQ expected 21.4 million euros.

The company said it now expects that its cash and cash equivalents of 66.3 million euros as of June 30 will fund its operations into Q4 2025, compared with the previously expected Q3 2025.